XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Ethics Channel
subscribe to Ethics newsletter

Special Topics : Ethics

   DISCUSS   |   EMAIL   |   PRINT
It is unethical for doctors to withhold information about expensive, unfunded drugs?
Nov 10, 2005, 18:50, Reviewed by: Dr.

�The gap between what we can do and what we can afford will continue to grow, at a personal and community level.�

 
It is unethical and paternalistic for doctors to withhold information from patients about new drugs that are not yet publicly funded, say researchers in this week�s BMJ.

New drugs may be more effective than existing treatments, but many are very expensive and may not be available through publicly funded health schemes.

This raises several ethical dilemmas for doctors. Is it reasonable to ask a patient to finance the full cost of their treatment when it is not provided by government? Would it be unethical to raise the option of treatment with an unsubsidised drug?

Researchers surveyed 184 Australian cancer specialists about their opinions and practices regarding potentially useful but unsubsidised drugs.

A large proportion said they would not discuss an expensive drug with a patient if it were not subsidised because of potential psychological and emotional effects that these discussions might have on patients and their families. The survey also found that these discussions were stressful for clinicians.

But the authors argue that this practice fails to respect autonomy and may not be in the patient�s best interests. They believe that withholding information on the basis of what a patient would want is �a dangerous medical path to unjustified paternalism.�

A further ethical issue concerns the cost of publicly funding newer, expensive treatments, they write. This is an urgent question of distributing limited resources fairly that faces not just new drugs, but many forms of modern technological care. �The gap between what we can do and what we can afford will continue to grow, at a personal and community level.�

The issue of accessing new expensive drugs has no easy solution, they say. Nevertheless, it seems unreasonable to withhold information from a patient about any potentially beneficial treatment because of concerns about capacity to pay, even if these discussions cause distress for some patients.

Society at large should discuss whether new, high-cost drugs should be publicly funded, they conclude.
 

- British Medical Journal, 5 November 2005 (Vol 331, No 7524)
 

http://bmj.com/cgi/content/full/331/7524/1075

 
Subscribe to Ethics Newsletter
E-mail Address:

 



Related Ethics News

Waiting For Trial Results Sometimes Unethical
NHGRI Funds Assessment of Public Attitudes About Population-Based Studies on Genes and Environment
Physicians More Likely To Disclose Medical Errors That Would Be Apparent To The Patient
Doctors inadvertently help terminally ill patients to die sooner
Intellectual property law and the protection of traditional knowledge
Conscientious objection in medicine should not be tolerated
Yale guidelines for physician interactions with pharmaceutical industry
Current interpretation of the data protection law is hampering epidemiological research
Massachusetts state can pull plug on comatose 11-year-old girl
Facial Transplants - Are they justified?


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us